Moderna DCGI approval
<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/u_sjSfIMxCE" title="YouTube video player" width="560"></iframe></p>
<p>
In a major development, pharma major Cipla has been cleared from DCGI to import Moderna&#39;s Covid vaccine for restricted emergency use in India. It will be the fourth vaccine to be administered in India after Covishield, Covaxin and Sputnik V. Moderna&#39;s Covid vaccine is an mRNA-based vaccine with an efficacy rate of 94.1 percent, according to a WHO estimate. Keep watching to know more!</p>
Following the threats issued by US-based Khalistani terrorist Gurpatwant Singh Pannun against Indian Ambassador to…
Indian Army Vice Chief Lieutenant General NS Raja Subramani, took part in the 80th-anniversary celebrations…
Ministry of External Affairs (MEA) spokesperson Randhir Jaiswal said on Friday India follows all developments…
Prime Minister Narendra Modi's visit to Kuwait is highly significant and is expected to elevate…
In a stride towards achieving self-reliance under the 'Atmanirbhar Bharat' vision, India's Product-Linked Incentive (PLI)…
The members of the 17th Tibetan Parliament-in-Exile have been actively advocating for Tibet in New…